Microbot Medical Inc. MBOT · Stock Open Microbot Medical Inc. in new tab
Microbot Medical Inc. Analysis (MBOT)
Is Microbot Medical Inc. a good investment? Microbot Medical Inc. (MBOT) is currently trading at 1.35 USD. Market analysts have a consensus price target of 6.67 USD. This suggests a potential upside from current levels.
Earnings Schedule: Microbot Medical Inc. is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -0.29.
Investor FAQ
Does Microbot Medical Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Microbot Medical Inc.?
Microbot Medical Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -0.25.
Company Profile
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
| Split Date | Split Ratio to 1 |
|---|---|
| July 6, 2011 | 1:10 |
| May 9, 2016 | 0.08 |
| Nov. 29, 2016 | 0.11 |
| Sept. 5, 2018 | 0.07 |
Community Discussion